Pfizer COVID Cash Rich Going Shopping In 2022

























Pfizer is definitely not a stupid company. Their forward p/e is low and attractive, and they delivered on Covid treatment unlike lying Gio. They get a solid pipeline and a very successful established product line.They probably would go after BMS, not AZN which is expensive.